{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:20:47Z","timestamp":1790313647313,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Council of Thailand"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70266-0","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T09:02:28Z","timestamp":1724144548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of pre-sarcopenia on outcomes of transarterial chemoembolization in unresectable hepatocellular carcinoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Attapon","family":"Rattanasupar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaporn","family":"Prateepchaiboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerati","family":"Akarapatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apiradee","family":"Songjamrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songklod","family":"Pakdeejit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunchai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"70266_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"70266_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"EASL Clinical Practice Guidelines","year":"2018","unstructured":"EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma. J. Hepatol. 69, 182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019 (2018).","journal-title":"J. Hepatol."},{"key":"70266_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero, J. A. et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology 68, 723\u2013750. https:\/\/doi.org\/10.1002\/hep.29913 (2018).","journal-title":"Hepatology"},{"key":"70266_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3350\/cmh.2016.22.1.7","volume":"22","author":"SJ Yu","year":"2016","unstructured":"Yu, S. J. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010\u20132016. Clin. Mol. Hepatol. 22, 7\u201317. https:\/\/doi.org\/10.3350\/cmh.2016.22.1.7 (2016).","journal-title":"Clin. Mol. Hepatol."},{"issue":"Suppl 1","key":"70266_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000368142","volume":"87","author":"M Kudo","year":"2014","unstructured":"Kudo, M. et al. Transarterial chemoembolization failure\/refractoriness: JSH-LCSGJ criteria 2014 update. Oncology 87(Suppl 1), 22\u201331. https:\/\/doi.org\/10.1159\/000368142 (2014).","journal-title":"Oncology"},{"key":"70266_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age Ageing 39, 412\u2013423. https:\/\/doi.org\/10.1093\/ageing\/afq034 (2010).","journal-title":"Age Ageing"},{"key":"70266_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/gut.2010.211292","volume":"60","author":"C Mancone","year":"2011","unstructured":"Mancone, C. et al. Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins. Gut 60, 378\u2013386. https:\/\/doi.org\/10.1136\/gut.2010.211292 (2011).","journal-title":"Gut"},{"key":"70266_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.21037\/qims-21-314","volume":"12","author":"Y Tan","year":"2022","unstructured":"Tan, Y. et al. Sarcopenia defined by psoas muscle index independently predicts long-term survival after living donor liver transplantation in male recipients. Quantitat. Imag. Med. Surg. 12, 215\u2013228. https:\/\/doi.org\/10.21037\/qims-21-314 (2022).","journal-title":"Quantitat. Imag. Med. Surg."},{"key":"70266_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00535-014-0964-9","volume":"50","author":"S Iritani","year":"2015","unstructured":"Iritani, S. et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J. Gastroenterol. 50, 323\u2013332. https:\/\/doi.org\/10.1007\/s00535-014-0964-9 (2015).","journal-title":"J. Gastroenterol."},{"key":"70266_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.31","volume":"6","author":"AJ Montano-Loza","year":"2015","unstructured":"Montano-Loza, A. J. et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin. Transl. Gastroenterol. 6, e102. https:\/\/doi.org\/10.1038\/ctg.2015.31 (2015).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"70266_CR11","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.3748\/wjg.v20.i25.8061","volume":"20","author":"AJ Montano-Loza","year":"2014","unstructured":"Montano-Loza, A. J. Clinical relevance of sarcopenia in patients with cirrhosis. World J. Gastroenterol. 20, 8061\u20138071. https:\/\/doi.org\/10.3748\/wjg.v20.i25.8061 (2014).","journal-title":"World J. Gastroenterol."},{"key":"70266_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jcsm.12039","volume":"7","author":"AJ Montano-Loza","year":"2016","unstructured":"Montano-Loza, A. J. et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J. Cachexia Sarcopenia Muscle 7, 126\u2013135. https:\/\/doi.org\/10.1002\/jcsm.12039 (2016).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"70266_CR13","doi-asserted-by":"publisher","unstructured":"Imai, K. et al. Sarcopenia impairs prognosis of patients with hepatocellular carcinoma: The role of liver functional reserve and tumor-related factors in loss of skeletal muscle volume. Nutrients. https:\/\/doi.org\/10.3390\/nu9101054 (2017).","DOI":"10.3390\/nu9101054"},{"key":"70266_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41598-022-27238-z","volume":"13","author":"Y Guo","year":"2023","unstructured":"Guo, Y., Ren, Y., Zhu, L., Yang, L. & Zheng, C. Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis. Sci. Rep. 13, 934. https:\/\/doi.org\/10.1038\/s41598-022-27238-z (2023).","journal-title":"Sci. Rep."},{"key":"70266_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000484950","volume":"7","author":"KV Chang","year":"2018","unstructured":"Chang, K. V. et al. Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: A systematic review and meta-analysis. Liver cancer 7, 90\u2013103. https:\/\/doi.org\/10.1159\/000484950 (2018).","journal-title":"Liver cancer"},{"key":"70266_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198812","volume":"13","author":"H Takada","year":"2018","unstructured":"Takada, H. et al. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma. PLoS One 13, e0198812. https:\/\/doi.org\/10.1371\/journal.pone.0198812 (2018).","journal-title":"PLoS One"},{"key":"70266_CR17","doi-asserted-by":"publisher","unstructured":"Yeh, W. S. et al. Pre-sarcopenia is the prognostic factor of overall survival in early-stage hepatoma patients undergoing radiofrequency ablation. Medicine 99, e20455, https:\/\/doi.org\/10.1097\/md.0000000000020455 (2020).","DOI":"10.1097\/md.0000000000020455"},{"key":"70266_CR18","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1038\/s41598-020-67147-7","volume":"10","author":"H Takada","year":"2020","unstructured":"Takada, H. et al. Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma. Sci. Rep. 10, 10186. https:\/\/doi.org\/10.1038\/s41598-020-67147-7 (2020).","journal-title":"Sci. Rep."},{"key":"70266_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/lt.24750","volume":"23","author":"EJ Carey","year":"2017","unstructured":"Carey, E. J. et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 23, 625\u2013633. https:\/\/doi.org\/10.1002\/lt.24750 (2017).","journal-title":"Liver Transpl."},{"key":"70266_CR20","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1080\/07853890.2022.2081872","volume":"54","author":"JX Zhang","year":"2022","unstructured":"Zhang, J. X. et al. Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization. Ann. Med. 54, 1562\u20131569. https:\/\/doi.org\/10.1080\/07853890.2022.2081872 (2022).","journal-title":"Ann. Med."},{"key":"70266_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado, C. M. et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 9, 629\u2013635. https:\/\/doi.org\/10.1016\/s1470-2045(08)70153-0 (2008).","journal-title":"Lancet Oncol."},{"key":"70266_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/hepr.12774","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa, H. et al. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol. Res. 46, 951\u2013963. https:\/\/doi.org\/10.1111\/hepr.12774 (2016).","journal-title":"Hepatol. Res."},{"key":"70266_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12664-021-01227-y","volume":"41","author":"T Prateepchaiboon","year":"2022","unstructured":"Prateepchaiboon, T. et al. Factors affecting prognosis in hepatocellular carcinoma patients post-transarterial chemoembolization. Indian J. Gastroenterol. 41, 352\u2013361. https:\/\/doi.org\/10.1007\/s12664-021-01227-y (2022).","journal-title":"Indian J. Gastroenterol."},{"key":"70266_CR24","doi-asserted-by":"publisher","unstructured":"Sato, Y. et al. Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602. Upsala J. Med. Sci. 118, 16\u201322. https:\/\/doi.org\/10.3109\/03009734.2012.729104 (2013).","DOI":"10.3109\/03009734.2012.729104"},{"key":"70266_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/s-2008-1040525","volume":"8","author":"BF Grant","year":"1988","unstructured":"Grant, B. F., Dufour, M. C. & Harford, T. C. Epidemiology of alcoholic liver disease. Semin. Liver Dis. 8, 12\u201325. https:\/\/doi.org\/10.1055\/s-2008-1040525 (1988).","journal-title":"Semin. Liver Dis."},{"key":"70266_CR26","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.4254\/wjh.v14.i6.1162","volume":"14","author":"A Rattanasupar","year":"2022","unstructured":"Rattanasupar, A. et al. Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization. World J. Hepatol. 14, 1162\u20131172. https:\/\/doi.org\/10.4254\/wjh.v14.i6.1162 (2022).","journal-title":"World J. Hepatol."},{"key":"70266_CR27","first-page":"1","volume":"1","author":"CG Child","year":"1964","unstructured":"Child, C. G. & Turcotte, J. G. Surgery and portal hypertension. Major Probl. Clin. Surg. 1, 1\u201385 (1964).","journal-title":"Major Probl. Clin. Surg."},{"key":"70266_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath, P. S. et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33, 464\u2013470. https:\/\/doi.org\/10.1053\/jhep.2001.22172 (2001).","journal-title":"Hepatology"},{"key":"70266_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken, M. M. et al. Toxicity and response criteria of the eastern cooperative oncology group. Am. J. Clin. Oncol. 5, 649\u2013655 (1982).","journal-title":"Am. J. Clin. Oncol."},{"key":"70266_CR30","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/hep.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal, A. G. et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78, 1922\u20131965. https:\/\/doi.org\/10.1097\/hep.0000000000000466 (2023).","journal-title":"Hepatology"},{"key":"70266_CR31","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00535-015-1068-x","volume":"50","author":"A Hiraoka","year":"2015","unstructured":"Hiraoka, A. et al. Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: Computed tomography is useful for evaluation. J. Gastroenterol. 50, 1206\u20131213. https:\/\/doi.org\/10.1007\/s00535-015-1068-x (2015).","journal-title":"J. Gastroenterol."},{"key":"70266_CR32","doi-asserted-by":"publisher","unstructured":"Loosen, S. H. et al. Sarcopenia is a negative prognostic factor in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies. Cancers. https:\/\/doi.org\/10.3390\/cancers11101503 (2019).","DOI":"10.3390\/cancers11101503"},{"key":"70266_CR33","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.3748\/wjg.v28.i36.5324","volume":"28","author":"G Roth","year":"2022","unstructured":"Roth, G. et al. Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World J. Gastroenterol. 28, 5324\u20135337. https:\/\/doi.org\/10.3748\/wjg.v28.i36.5324 (2022).","journal-title":"World J. Gastroenterol."},{"key":"70266_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00535-020-01711-w","volume":"55","author":"G Marasco","year":"2020","unstructured":"Marasco, G. et al. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J. Gastroenterol. 55, 927\u2013943. https:\/\/doi.org\/10.1007\/s00535-020-01711-w (2020).","journal-title":"J. Gastroenterol."},{"key":"70266_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejim.2016.07.017","volume":"35","author":"G Vitale","year":"2016","unstructured":"Vitale, G., Cesari, M. & Mari, D. Aging of the endocrine system and its potential impact on sarcopenia. Eur. J. Intern. Med. 35, 10\u201315. https:\/\/doi.org\/10.1016\/j.ejim.2016.07.017 (2016).","journal-title":"Eur. J. Intern. Med."},{"key":"70266_CR36","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/s0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. & Sayer, A. A. Sarcopenia. Lancet 393, 2636\u20132646. https:\/\/doi.org\/10.1016\/s0140-6736(19)31138-9 (2019).","journal-title":"Lancet"},{"key":"70266_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4783","volume":"3","author":"GR Williams","year":"2020","unstructured":"Williams, G. R. et al. Assessment of sarcopenia measures, survival, and disability in older adults before and after diagnosis with cancer. JAMA Netw. Open 3, e204783. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.4783 (2020).","journal-title":"JAMA Netw. Open"},{"key":"70266_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jhbp.302","volume":"23","author":"A Kobayashi","year":"2016","unstructured":"Kobayashi, A. et al. Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma. J. Hepatobiliary Pancreat. Sci. 23, 57\u201364. https:\/\/doi.org\/10.1002\/jhbp.302 (2016).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"70266_CR39","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1245\/s10434-014-3686-6","volume":"21","author":"S Itoh","year":"2014","unstructured":"Itoh, S. et al. Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma. Ann. Surg. Oncol. 21, 3063\u20133068. https:\/\/doi.org\/10.1245\/s10434-014-3686-6 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"70266_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","volume":"63","author":"N Fujiwara","year":"2015","unstructured":"Fujiwara, N. et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J. Hepatol. 63, 131\u2013140. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.031 (2015).","journal-title":"J. Hepatol."},{"key":"70266_CR41","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/lt.23495","volume":"18","author":"P Tandon","year":"2012","unstructured":"Tandon, P. et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 18, 1209\u20131216. https:\/\/doi.org\/10.1002\/lt.23495 (2012).","journal-title":"Liver Transpl."},{"key":"70266_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000367749","volume":"5","author":"T Kaido","year":"2016","unstructured":"Kaido, T. Selection criteria and current issues in liver transplantation for hepatocellular carcinoma. Liver Cancer 5, 121\u2013127. https:\/\/doi.org\/10.1159\/000367749 (2016).","journal-title":"Liver Cancer"},{"key":"70266_CR43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/hepr.12780","volume":"47","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka, A. et al. Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib. Hepatol. Res. 47, 558\u2013565. https:\/\/doi.org\/10.1111\/hepr.12780 (2017).","journal-title":"Hepatol. Res."},{"key":"70266_CR44","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12885-018-4673-2","volume":"18","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi, T. et al. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer 18, 756. https:\/\/doi.org\/10.1186\/s12885-018-4673-2 (2018).","journal-title":"BMC Cancer"},{"key":"70266_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.clnesp.2019.07.011","volume":"33","author":"J Vasques","year":"2019","unstructured":"Vasques, J., Guerreiro, C. S., Sousa, J., Pinto, M. & Cortez-Pinto, H. Nutritional support in cirrhotic patients with sarcopenia. Clin. Nutrit. ESPEN 33, 12\u201317. https:\/\/doi.org\/10.1016\/j.clnesp.2019.07.011 (2019).","journal-title":"Clin. Nutrit. ESPEN"},{"key":"70266_CR46","doi-asserted-by":"publisher","unstructured":"Brustia, R., Savier, E. & Scatton, O. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis. Clin. Res. Hepatol. Gastroenterol. 42, 205\u2013215, https:\/\/doi.org\/10.1016\/j.clinre.2017.09.005 (2018).","DOI":"10.1016\/j.clinre.2017.09.005"},{"key":"70266_CR47","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1002\/jcsm.13040","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma. J. Cachexia Sarcopenia Muscle 13, 2383\u20132392. https:\/\/doi.org\/10.1002\/jcsm.13040 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"70266_CR48","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1111\/hepr.12718","volume":"47","author":"S Koya","year":"2017","unstructured":"Koya, S. et al. Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease. Hepatol. Res. 47, E22-e34. https:\/\/doi.org\/10.1111\/hepr.12718 (2017).","journal-title":"Hepatol. Res."},{"key":"70266_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40644-023-00575-6","volume":"23","author":"K Bannangkoon","year":"2023","unstructured":"Bannangkoon, K., Hongsakul, K. & Tubtawee, T. Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate-stage hepatocellular carcinoma undergoing chemoembolization. Cancer Imag. 23, 51. https:\/\/doi.org\/10.1186\/s40644-023-00575-6 (2023).","journal-title":"Cancer Imag."},{"key":"70266_CR50","doi-asserted-by":"publisher","first-page":"1077842","DOI":"10.3389\/fmed.2023.1077842","volume":"10","author":"A Kaewdech","year":"2023","unstructured":"Kaewdech, A. et al. FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): A model to predict intermediate-stage HCC patients who are not good candidates for TACE. Front. Med. 10, 1077842. https:\/\/doi.org\/10.3389\/fmed.2023.1077842 (2023).","journal-title":"Front. Med."},{"key":"70266_CR51","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2147\/jhc.S407646","volume":"10","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. A novel neutrophil-to-lymphocyte ratio and sarcopenia based TACE-predict model of hepatocellular carcinoma patients. J. Hepatocell. Carcinoma 10, 659\u2013671. https:\/\/doi.org\/10.2147\/jhc.S407646 (2023).","journal-title":"J. Hepatocell. Carcinoma"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70266-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70266-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70266-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T09:15:49Z","timestamp":1724145349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70266-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70266-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19249"}}